|
Adverse Effects
Citations 11-20 of 402 total displayed.
|
Past content
(since May 1998):
|
- Editor's Correspondence
The Case for Dual Renin-Angiotensin System Inhibition
- Sheldon Hirsch
Arch Intern Med 2009; 169: 1931.
[Extract]
[Full text]
[PDF]
- Editorials
Adverse Events in Randomized Trials: Neglected, Restricted, Distorted, and Silenced
- John P. A. Ioannidis
Arch Intern Med 2009; 169: 1737-1739.
[Extract]
[Full text]
[PDF]
- Commentaries
Going Off-label Without Venturing Off-Course: Evidence and Ethical Off-label Prescribing
- Emily A. Largent; Franklin G. Miller; Steven D. Pearson
Arch Intern Med 2009; 169: 1745-1747.
[Extract]
[Full text]
[PDF]
- Original Investigations
Reporting of Safety Results in Published Reports of Randomized Controlled Trials
- Isabelle Pitrou; Isabelle Boutron; Nizar Ahmad; Philippe Ravaud
Arch Intern Med 2009; 169: 1756-1761.
[Abstract]
[Full text]
[PDF]
[ eAppendix ]
- Original Investigations
Evaluating the Incremental Benefits of Raising High-Density Lipoprotein Cholesterol Levels During Lipid Therapy After Adjustment for the Reductions in Other Blood Lipid Levels
- Steven A. Grover; Mohammed Kaouache; Lawrence Joseph; Philip Barter; Jean Davignon
Arch Intern Med 2009; 169: 1775-1780.
[Abstract]
[Full text]
[PDF]
- Editorials
Can the Food and Drug Administration Ensure That Our Pharmaceuticals Are Safely Manufactured?
- William K. Hubbard
Arch Intern Med 2009; 169: 1655-1656.
[Extract]
[Full text]
[PDF]
- Original Investigations
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter: A Population-Based, Case-Control Study
- Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R. Cummings; Roland D. Chapurlat; Henrik Toft Sørensen
Arch Intern Med 2009; 169: 1677-1683.
[Abstract]
[Full text]
[PDF]
[ eAppendix ]
- Original Investigations
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
- Carolyn J. Crandall; Aaron K. Aragaki; Rowan T. Chlebowski; Anne McTiernan; Garnet Anderson; Susan L. Hendrix; Barbara B. Cochrane; Lewis H. Kuller; Jane A. Cauley
Arch Intern Med 2009; 169: 1684-1691.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Multistate Outbreak of Serratia marcescens Bloodstream Infections Caused by Contamination of Prefilled Heparin and Isotonic Sodium Chloride Solution Syringes
- David Blossom; Judith Noble-Wang; John Su; Stacy Pur; Roy Chemaly; Alicia Shams; Bette Jensen; Neil Pascoe; Jessica Gullion; Eric Casey; Mary Hayden; Matthew Arduino; Daniel S. Budnitz; Isaam Raad; Gordon Trenholme; Arjun Srinivasan; for the Serratia in Prefilled Syringes Investigation Team Group
Arch Intern Med 2009; 169: 1705-1711.
[Abstract]
[Full text]
[PDF]
- Editor's Correspondence
Pharmacists Are Key to Enhancing Benefit Risk for Medicines—Reply
- Michael D. Murray
Arch Intern Med 2009; 169: 1723-a-1724-a.
[Extract]
[Full text]
[PDF]
|
|
